Pursuing the expanded access process for treatment may be the best option for patients who have exhausted all available FDA-approved drugs and clinical trials.
Triptans are contraindicated in patients with ischemic heart disease, cerebrovascular disease, uncontrolled hypertension, and peripheral artery disease.
Oritavancin (Orbactiv) is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms.
Desitin is used to provide relief of skin irritation caused by a diaper rash.
Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how the COVID-19 pandemic has changed the role of pharmacy technicians and what is expected as we move forward.
The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Cultural competence should be thought in terms of being cognizant that there are differences in every single patient.
After noticing that there were few, if any, children’s books on the subject, Katrina Zearley wrote and published I Think When I Am Older I Might Be a Pharmacist!
Women, in particular, suffer more severe cardiovascular and other complications related to diabetes.
Patient education, naloxone training, and monitoring programs make a difference.
In 2020, there was a 17% decrease in new HIV diagnoses and significant reductions in HIV testing in health care and non-health care settings, impeding the Ending the HIV Epidemic initiative to increase testing and reduce infections.
A recent case report detailing multiple procedures and inconclusive biopsies underwent by a patient with unusual presentation of immunoglobulin G4-related disease before conclusive diagnosis emphasizes the importance of follow-up with patients with suspicion of systemic disease.
Dutch biopharmaceutical company Byondis submitted the BLA for [vic-]trastuzumab duocarmazine (SYD985) in the treatment of patients with HER2-positive metastatic breast cancer with the goal of improving patient outcomes.
A pharmacist’s role in the ambulatory care setting has traditionally included a review of medications for potential drug-drug interactions and adverse events, medication reconciliation, and the provision of counseling services.
This year's events are intended to invite members of Congress to visit the pharmacy to help solidify conversations surrounding pharmacy issues.
NVX-CoV2373, a protein-based COVID-19 vaccine, may increase the country's vaccination rate for those hesitant to receive other vaccines.
Liraglutide (Saxenda) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with type 2 diabetes.
Calmoseptine is used to treat irritation caused by skin rashes.
CS Family Pharmacy has migrated to a combo-type pharmacy, integrating long term care.
Bunch Pharmacy has been in business for 24 years in the rural area of Alabama.
Some anti-abortion laws may lead to legal action against health care providers who prescribe or provide medications that can be used to induce abortions.
Each technology should be evaluated on its own merit and, importantly, in appropriate context for your organization given other resources.
With a coordinated, interprofessional team supporting them, patients are empowered with information at the point-of-care to help manage medication therapy problems as they arise.
Moderna is completing regulatory submissions for mRNA-1273.214 in preparation for the fall booster season, based on clinical data showing that the booster candidate has a significantly higher neutralizing antibody response against all tested variants including Omicron BA.4/5.
From the first approved CAR T therapy for multiple myeloma, to the recently-approved ciltacabtagene autoleucel, significant steps have been taken.
The FDA has approved fam-trastuzumab deruxtecan-nxki (Enhertu) for previously treated HER2-positive breast cancer and gastric or gastroesophageal junction adenocarcinoma.
The FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.
A booster dose of both Omicron-adapted vaccine candidates elicited a substantially higher immune response against Omicron BA.1.
Community pharmacists are vulnerable to security threats, resulting in bad outcomes for both patients and pharmacies. Here’s how to evaluate risk and find the right technology partner to help protect and defend you from cybercriminals.
